Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Status:
Completed
Trial end date:
2017-08-24
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to compare chemotherapy given with rituximab to
chemotherapy followed by rituximab. The safety of both treatment schedules will be studied.
Laboratory tests of genetic changes in blood and bone marrow before and during the study will
also be monitored.